Abstract: A method for fabricating a semiconductor device is provided. The method includes the actions of: providing on a substrate comprising an etch stop layer formed on the substrate; forming a stacked structure on the etch stop layer, the stacked structure including a lower pattern and at least one upper pattern, wherein each of the lower pattern and the at least one upper pattern includes a sacrificial layer and a support layer formed on the sacrificial layer; forming a hole penetrating the stacked structure and the etch stop layer; forming a lower conductive pattern in the hole; forming an opening penetrating the at least one upper pattern and the support layer of the lower pattern by a first etch process; and removing the sacrificial layers of the lower pattern and the at least one upper pattern by a second etch process.

Abstract: The present disclosure provides a method of forming high aspect ratio (HAR) features in a semiconductor substrate. The substrate is placed in a processing chamber of an etching apparatus. A first nitride layer of the substrate is etched towards a first oxide layer of the substrate for a predetermined duration. The first oxide layer of the substrate is etched towards a second nitride layer of the substrate while monitoring a parameter in the processing chamber by an end point detector of the etching apparatus. A control unit of the etching apparatus determines whether the parameter in the processing chamber detected by the end point detector exceeds a predetermined value. If the parameter detected by the end point detector exceeds the predetermined value, an etching end point is marked for the first oxide layer of the substrate.

Abstract: A vehicle running control method includes: acquiring, at least one of a first traveling state information of an autonomous vehicle and a second traveling state information of adjacent vehicles traveling in a traveling lane or in a lane adjacent to the traveling lane through a sensor unit; determining, by a determination processor, a candidate cut-in vehicle that travels behind the autonomous vehicle among the adjacent vehicles based on the first and second traveling state information; searching, by a controller, for a potential cut-in space, which is determined based on the relative velocity of a preceding vehicle that is the closest to the autonomous vehicle among the adjacent vehicles and the distance between the preceding vehicle and the autonomous vehicle; and performing, by the controller, deceleration, acceleration, or velocity maintenance of the autonomous vehicle depending on whether the potential cut-in space is present.

Abstract: A vehicle running control method includes: when a junction section lane is present adjacent to a traveling lane of a host vehicle, collecting, by a processor, vehicle information of at least one vehicle traveling in the junction section lane; determining, by the processor, the possibility of cut-in of junction section lane vehicles based on the collected vehicle information and whether the traveling lane is congested; and controlling, by the processor, at least one of the traveling path or the traveling velocity of the host vehicle based on the result of determination in order to display an intention to yield.

Abstract: A broadcast receiving for updating service map information by scanning the broadcast signal when signaling information included in a broadcast signal has been changed.

Abstract: Provided are a composition for diagnosing vascular disease including an agent measuring a level of interleukin 12 receptor ?2 protein in the blood, and a kit for diagnosing vascular disease including the same. Further, provided is a method for diagnosing vascular disease, the method including the step of measuring a level of interleukin 12 receptor ?2 protein in a blood sample separated from an individual suspected of having vascular disease. Furthermore, provided are a composition for preventing or treating vascular disease including an interleukin 12 receptor ?2 activity inhibitor, and a method of screening a therapeutic agent for vascular disease, the method including the step of treating smooth muscle cells with a test agent for vascular disease treatment and measuring an expression level of interleukin 12 receptor ?2.

Abstract: An electronic device is provided. The electronic device includes a processor, and a memory configured to store a messenger application, wherein the processor is configured to output the messenger application on the display and output a list of chat rooms joined based on a first user account on the display, and wherein the list of the plurality of chat rooms comprises a first chat room, in which the electronic device participates, and a second chat room in which another electronic device participates.

Abstract: The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for preparing a compound represented by Chemical Formula 1 having improved intracellular permeability and mimicking the activity of 2-Cys-Prx in its reduced form in the cells; a pharmaceutical composition for preventing or treating vascular diseases comprising an epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient; a drug delivery device for local administration including the pharmaceutical composition; and a pharmaceutical composition for inhibiting melanoma metastasis comprising the epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient.

Abstract: A broadcast receiving for updating service map information by scanning the broadcast signal when signaling information included in a broadcast signal has been changed.

Abstract: An electronic device is provided. The electronic device includes a display, a processor, and a memory storing a first application program including a first user interface and a second application program including a second user interface. The memory stores instructions that, when executed, cause the processor to display an array of icons in an area adjacent to the edge in response to the gesture input, wherein each of the icons has a first size, one of the icons includes a first icon and a second icon, the first icon and second icon having a second size smaller than the first size, the first icon indicates the first application program, and the second icon indicates the second application program, receive an input to select the one of the icons, and display the first user interface and the second user interface together on the display in response to the received input.

Abstract: Disclosed may be a method for controlling counter steering of a vehicle, which, in a counter steering section for controlling over-steer while a vehicle travels a curve, prevents lateral force from being decreased by maintaining a braking pressure according to an operation of an antilock braking system (ABS) for a vehicle wheel (a front axle curve-travelling outer wheel) of a counter steering target at an optimal slip level (before an improvement of a target slip), and improves steering performance by forming a linear yaw rate in a direction for counter steering without a delay in forming the yaw rate.

Abstract: Provided is a high heat resistant brake disk for a railroad vehicle, which is manufactured using a nano material having high heat conductivity, such as a carbon nanotube (CNT) or graphene, to improve heat resistance of an overheated portion of the brake disk, and which can extend a life of the brake disk by suppressing performance deterioration due to a thermal shock. The high heat resistant brake disk includes a hub inserted into an axle of the railroad vehicle and an outer circumference coupled to a vehicle wheel to coaxially rotate with the vehicle wheel, wherein at least one pattern unit made from a high heat resistant nano material is formed on one surface of the brake disk.

Abstract: The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for preparing a compound represented by Chemical Formula 1 having improved intracellular permeability and mimicking the activity of 2-Cys-Prx in its reduced form in the cells; a pharmaceutical composition for preventing or treating vascular diseases comprising an epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient; a drug delivery device for local administration including the pharmaceutical composition; and a pharmaceutical composition for inhibiting melanoma metastasis comprising the epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient.

Abstract: The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for preparing a compound represented by Chemical Formula 1 having improved intracellular permeability and mimicking the activity of 2-Cys-Prx in its reduced form in the cells; a pharmaceutical composition for preventing or treating vascular diseases comprising an epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient; a drug delivery device for local administration including the pharmaceutical composition; and a pharmaceutical composition for inhibiting melanoma metastasis comprising the epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient.

Abstract: Provided are a composition for diagnosing vascular disease including an agent measuring a level of interleukin 12 receptor ?2 protein in the blood, and a kit for diagnosing vascular disease including the same. Further, provided is a method for diagnosing vascular disease, the method including the step of measuring a level of interleukin 12 receptor ?2 protein in a blood sample separated from an individual suspected of having vascular disease. Furthermore, provided are a composition for preventing or treating vascular disease including an interleukin 12 receptor ?2 activity inhibitor, and a method of screening a therapeutic agent for vascular disease, the method including the step of treating smooth muscle cells with a test agent for vascular disease treatment and measuring an expression level of interleukin 12 receptor ?2.

Abstract: The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for preparing a compound represented by Chemical Formula 1 having improved intracellular permeability and mimicking the activity of 2-Cys-Prx in its reduced form in the cells; a pharmaceutical composition for preventing or treating vascular diseases comprising an epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient; a drug delivery device for local administration including the pharmaceutical composition; and a pharmaceutical composition for inhibiting melanoma metastasis comprising the epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient.

Abstract: Disclosed may be a method for controlling counter steering of a vehicle, which, in a counter steering section for controlling over-steer while a vehicle travels a curve, prevents lateral force from being decreased by maintaining a braking pressure according to an operation of an antilock braking system (ABS) for a vehicle wheel (a front axle curve-travelling outer wheel) of a counter steering target at an optimal slip level (before an improvement of a target slip), and improves steering performance by forming a linear yaw rate in a direction for counter steering without a delay in forming the yaw rate.

Abstract: The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for preparing a compound represented by Chemical Formula 1 having improved intracellular permeability and mimicking the activity of 2-Cys-Prx in its reduced form in the cells; a pharmaceutical composition for preventing or treating vascular diseases comprising an epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient; a drug delivery device for local administration including the pharmaceutical composition; and a pharmaceutical composition for inhibiting melanoma metastasis comprising the epidithiodioxopiperazine compound or its derivatives or pharmaceutically acceptable salts thereof as an active ingredient.

Abstract: A microwave oven that includes a power supply and a heating bar connected to the power supply is described. The heating bar is configured to receive an electric current from the power supply, and to apply the current to food. The electric current applied from the heating bar passes through the food thereby heating up the food.

Abstract: An electronic device is provided. The electronic device includes a processor, and a memory configured to store a messenger application, wherein the processor is configured to output the messenger application on the display and output a list of chat rooms joined based on a first user account on the display, and wherein the list of the plurality of chat rooms comprises a first chat room, in which the electronic device participates, and a second chat room in which another electronic device participates.